Alzheimer’s disease is one of the most common and serious brain conditions in the world today. It affects millions of people, especially older adults, and it slowly damages memory, thinking, and daily functioning.
People with Alzheimer’s may first notice small problems, like forgetting names or misplacing items. Over time, these problems become much more severe. They may struggle to recognize loved ones, follow conversations, or take care of themselves. This is why Alzheimer’s is often described as a progressive disease, because it gets worse as time goes on.
For many years, scientists have tried to understand what causes Alzheimer’s and how to detect it early. One well-known feature of the disease is the buildup of harmful substances in the brain. These include sticky clumps called beta-amyloid plaques and twisted fibers known as tangles.
These substances damage brain cells and stop them from working properly. However, these changes often begin many years before a person shows any clear symptoms. This makes early detection very difficult.
A new study has brought fresh hope to this problem. Researchers from the University of California San Diego have found a possible early warning sign that could be detected with a simple blood test. The study was led by Professor Sheng Zhong and was published in the scientific journal Cell Metabolism. Their work focuses on a substance in the body called PHGDH.
PHGDH is an enzyme, which means it is a special type of protein that helps the body carry out chemical processes. In this case, PHGDH helps produce an amino acid called serine. Serine is important for building proteins and supporting brain health. Under normal conditions, the body carefully controls how much PHGDH it produces.
In this new research, scientists discovered that people with Alzheimer’s disease have much higher levels of PHGDH than normal. What is especially important is that this increase can happen even before a person starts to show memory loss or confusion. This suggests that PHGDH could act as an early signal that Alzheimer’s is developing.
To study this, the researchers examined brain samples and genetic data from people aged 50 and older. These samples came from four different groups of participants, including healthy individuals, people with early brain changes, and people diagnosed with Alzheimer’s disease. Each group included around 40 to 50 people.
Across all groups, the results were very consistent. People with Alzheimer’s had much higher levels of PHGDH compared to those without the disease.
The researchers also found a strong link between PHGDH levels and thinking ability. People with higher levels of this enzyme tended to perform worse on memory and thinking tests. This shows a clear connection between PHGDH and the decline in brain function.
To make sure their findings were reliable, the scientists also tested mice that were genetically designed to develop Alzheimer’s-like symptoms. These mice showed the same pattern. They had higher levels of PHGDH in their brains, just like human patients. This strengthens the idea that PHGDH is closely linked to the disease.
One unexpected part of the study relates to serine supplements. Some people take serine as a health supplement because it is believed to support brain function. However, since PHGDH produces serine, and Alzheimer’s patients already have too much PHGDH activity, this could mean their brains are already producing too much serine.
The researchers warn that taking extra serine might not be safe for people at risk of Alzheimer’s. More research is needed, but this finding suggests people should be careful with such supplements.
The discovery of PHGDH is important because it could lead to a simple blood test to detect Alzheimer’s early. At the moment, diagnosing Alzheimer’s often requires brain scans or detailed memory testing, which can be expensive and may only detect the disease after damage has already occurred.
A blood test would be much easier and could help doctors identify at-risk individuals years earlier.
Although there is still no cure for Alzheimer’s disease, early detection could make a big difference. It could allow people to start treatment earlier and make lifestyle changes that may slow the disease. For example, regular physical activity can improve blood flow to the brain and support brain health.
Eating a balanced diet, especially one rich in fruits, vegetables, whole grains, and healthy fats, is also helpful. Staying mentally active by reading, learning new skills, or socializing with others can help keep the brain strong.
Managing health conditions like high blood pressure, diabetes, and high cholesterol is also important because these conditions can affect brain health.
This study is a major step forward in Alzheimer’s research. By identifying PHGDH as a possible early marker, scientists are getting closer to finding better ways to detect and treat this disease.
While more work is needed, this discovery gives hope that in the future, Alzheimer’s could be identified much earlier, giving patients and families more time to prepare and respond.
If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and strawberries can be good defence against Alzheimer’s.
For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
